Kathmandu, Jan. 6 -- The Department of Drug Administration (DDA) has recalled a third-generation antibiotic, Levoflox-500 tablet, after the medicine was found substandard in laboratory testing.

The medicine's batch, BB24001, manufactured by Bara-based Magnus Pharma Pvt Ltd failed to meet IP 2022 standards in the dissolution test, according to the department, which is also the national regulatory body for both allopathic and ayurvedic medicines.

"Recalling the substandard drug from the pharmacies is our prime duty," said Narayan Dhakal, director general at the department. "The measure has been taken to ensure quality of drug, for risk mitigation and also to make manufacturers accountable."

Levoflox 500 mg tablet, also known as Levofloxa...